Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, the discussions demonstrate high interest, with participants referencing specific triggers such as Borrelia toxin and neuropsychiatric symptoms, and some engage deeply by connecting the research to broader clinical challenges. The tone is analytical and somewhat optimistic about the potential implications for diagnosis and treatment.
Most discussions acknowledge the importance of recent research, with some referencing the role of Borrelia toxin as a trigger, indicating at least moderate agreement with the article's significance.
The prominence of the topic across multiple posts, including mentions of triggers like Borrelia and discussions on mediators, reflects high interest among participants.
Some posts engage deeply by referencing specific elements of the research, such as triggers, neuropsychiatric symptoms, and diagnostic challenges, though not all contribute detailed analysis.
The discussions suggest that the research is viewed as potentially impactful, especially in understanding complex disorders like MCAS and their triggers, but without expressing outright revolutionary changes yet.
@LonnieRhea Donta hypothesized there was a Bb toxin, and looked w/no luck- albeit with older tools. I was surprised to see “Borrelia toxin” listed as one of the “Unappreciated triggers” of MCAS in this recent paper by Theoharides et al. at Tufts. https://t.co/Tk1VcW4wTR
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? (Comorbidity w/PTLDS; also Bb as a trigger) https://t.co/InmK9faSBS
Theoharides | Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? #ILADSboston2019 https://t.co/M3c7K6CyYC
@ChronicWholenes you can get full paper on sci hub https://t.co/INdoQOE75w
Recent advances in our understanding of #mastcell activation – or should it be mast cell mediator disorders?. https://t.co/u4hwcem680 #Histamine #VitaminC #Inflammation #OxidativeStress #Treg #Immunotherapy #MCAS #MECFS https://t.co/QtiyLhPtZ5
RT @WhatsLeftOfTheD: Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? (Comorb…
This video discusses luteolin as a supplement for autism, based on studies by Dr. Theoharides showing its potential to reduce symptoms. It covers recent research on mast cell activation and its role in neuropsychiatric…
Recent research highlights that mast cell activation, or mast cell mediator disorders, can cause symptoms across multiple organs, including the brain, due to the release of various mediators. Focus on identifying…
RT @WhatsLeftOfTheD: @LonnieRhea Donta hypothesized there was a Bb toxin, and looked w/no luck- albeit with older tools. I was surprised to…
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? By Theoharis C. Theoharides, Irene Tsilioni, and Huali Rene https://t.co/u9Pzpod8zO Expert Rev Clin Immunol. 2019 Jun; 15(6): 639–656.
@LonnieRhea Donta hypothesized there was a Bb toxin, and looked w/no luck- albeit with older tools. I was surprised to see “Borrelia toxin” listed as one of the “Unappreciated triggers” of MCAS in this recent paper by Theoharides et al. at Tufts. https://t.co/Tk1VcW4wTR
Theoharides | Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? #ILADSboston2019 https://t.co/M3c7K6CyYC
RT @WhatsLeftOfTheD: Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? (Comorb…
RT @WhatsLeftOfTheD: Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? (Comorb…
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? (Comorbidity w/PTLDS; also Bb as a trigger) https://t.co/InmK9faSBS
@ChronicWholenes you can get full paper on sci hub https://t.co/INdoQOE75w
Recent advances in our understanding of #mastcell activation – or should it be mast cell mediator disorders?. https://t.co/u4hwcem680 #Histamine #VitaminC #Inflammation #OxidativeStress #Treg #Immunotherapy #MCAS #MECFS https://t.co/QtiyLhPtZ5
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? Theoharis C. Theoharides,Irene Tsilioni & Huali Ren https://t.co/cPk3ynm8tI
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?: Expert Review of Clinical Immunology: https://t.co/VqCdZMMg39
doi:10.1080/1744666X.2019.1596800. 619. DRAFT. Page 108. 2025 Annual Meeting. Science and Public Health. © 2025 American Medical Association. All rights ...
https://doi.org/10.1080/1744666X.2019.1596800 · Crossref. See more. Loading... Citation information is sourced from Crossref Cited-by service. View Options ...
https://doi.org/10.1080/1744666X.2019.1596800. 233 Babu, K. S., Polosa, R., & Morjaria, J. B. (2013). Anti-IgE--emerging opportunities for Omalizumab. Expert ...
... 10.1080/15265161.2019.1618957. 39. Mikow-Porto VA, Smith TA. The IHSSF 2011 ... 1744666X.2019.1596800. 175. Theoharides TC. Autism Spectrum Disorders and ...
https://doi.org/10.1080/1744666X.2019.1596800. GO TO NOTE REFERENCE IN TEXT. associated with mast-cell activation: Lawrence B. Afrin, “Mast Cell Activation ...
108 likes, 2 comments - apometriaclinica on December 1, 2025.
... 10.1080/1744666X.2019.1596800 · https://karger.com/iaa/article/157/3/215/167326 · https://www.mdpi.com/1422-0067/21/23/9030 · https://europepmc ...
doi: 10.1080/1744666X.2019.1596800. 6月Epub 2019 4月22. PMID: 30884251. [PMC 免费文章] [PubMed] [CrossRef]. Theoharides T.C. COVID-19、肺肥大 ...
doi: 10.1080/1744666X.2019.1596800. Jun Epub 2019 Apr 22. PMID: 30884251. [PMC free article] [PubMed] [CrossRef]. Theoharides T.C. COVID-19 ...
DC
LO
S
BH
LB
RN
GH
A
S